Screening of prostate cancer in asymptomatic men over 50 years is subject to discussion. A review of the medical and economical arguments in favor and against screening is given. It is concluded that widespread screening should not be undertaken but that correct information of the population is necessary with an adapted response to individual demands.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1159/000474524 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!